John M. Climaco, Chief Executive Officer at CNS Pharmaceuticals, Inc. (CNSP), bought 2,750 shares at $1.80 ($5K) on 2023-08-16, disclosed to the SEC on 2023-08-16.
Open-market purchase of $5k CNSP by Chief Executive Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| DRAD | BUY | 2019-03-18 | $5K | — | Filing → |
| DRAD | BUY | 2013-11-14 | $40K | — | Filing → |
| DRAD | BUY | 2013-10-03 | $10K | — | Filing → |